img

Biobank

From the K-Biobank to global biobanks, we are leading the platformization of databases by combining bio big data with analytical technology.

  • icon

    COCD Platform

    (Clinico-Omics Cohort Database Platform)

    The COCD Platform is Basgenbio's cohort database platform, including a total of 730,000 clinico-omics data, centered around K-Biobank and global biobanks such as UKB and ADNI. This platform contains information on various diseases, including cancer, chronic diseases, and autoimmune diseases.

    COCD Platform

    K-Biobank
    • Blood Sample (156K+)
    • Clinical Data Diagnosis, Treatment, Prescription Drug Information
    • Lifestyle Data Smoking, Alcohol Consumption, Exercise Status
    • Genomic Data DNA Micro-array Data
    Other Biobank
    • UK Biobank (500K+)
    • Korean
    • The Cancer Genome Atlas (TCGA) (10K+)
    • Genomic DataAlzheimer's Disease
      Neuroimaging Initiative (ADNI) (2K+)
    Data Sources (Scheduled for Acquisition)
    Multi-Omics Data
    Genomics Metabolomics Proteomics Transcriptomics Microbiome …
    • 50K Blood Sample (Rare Disease)
    • 1K Blood Sample (Aging Biobank Cohort)
    UK Biobank

    (United Kingdom Biobank)

    500K+

    Support Research on Serious and
    Life-Threatening Illnesses

    Primarily British With Some Other Ethnic Groups

    Korean

    confidential
    K-Biobank
    156K+

    Genomics, Clinical and life style information for
    serous and life-threatening Illnesses

    Korean

    TCGA

    (The Cancer Genome Atlas)

    10K+

    Advance Understanding of Cancer
    Through Genomic and Clinical Data

    Diverse Ethnic Backgrounds

    ADNI

    (The Alzheimer’s Disease Neuroimaging Initiative)

    2K+

    Accelerate the Development of Effective
    Treatments and Diagnostics for Alzheimer’s
    Disease and Related Dementias

    Primarily Non-Hispanic
    With Some Other Ethnic Groups

    Rare Disease Biobank
    *Scheduled for Acquisition
    Aging Biobank Cohort
    *Scheduled for Acquisition
    Etc
    *Scheduled for Acquisition
    icon

    K-Biobank

    Largest Private Biobank in South Korea

    K-Biobank stores blood samples from 156,000 subjects collected since 2005 from various medical institutions, including Yonsei Medical Center, major university hospitals, and health checkup centers. Its data scope is being expanded by linking clinical records and lifestyle information accumulated in government agencies such as the National Health Insurance Service, National Cancer Center, and Statistics Korea. Basgenbio conducts research and development activities based on K-Biobank, including drug efficacy simulation. genetic and environmental factor analysis related to disease occurrence, and scientific research results related to disease prevention, diagnosis, treatment, and prognosis.

    *Year of Acquisition: 2021
    icon

    UK Biobank

    World's Largest Private Biobank

    UK Biobank consists of a large-scale cohort database with genetic and health data from 500,000 residents across the UK. Basgenbio analyzes data from global biobanks like this for research on disease prediction , drug response marker, and drug target validation.

    *Year of Acquisition: 2021
    icon

    ADNI

    Alzheimer's Disease Neuroimaging Initiative (ADNI)

    ADNI is a multi-institutional, longitudinal, and prospective research database involving research teams from 63 regions in the United States and Canada. It tracks the progression of Alzheimer's disease using brain imaging, biochemical, and genetic biomarkers. It includes information on normal cognitive aging, mild cognitive impairment, and early Alzheimer's disease patients, allowing for multidimensional analysis. Basgenbio analyzes ADNI data for the discovery of drug response markers and targets related to Alzheimer's disease, as well as external validation.

    *Year of Acquisition: 2021
    icon

    TCGA

    The Cancer Genome Atlas (TCGA)

    TCGA is a project started in 2005 aimed at the integrated accumulation of cancer genetic mutation data and biological information analysis. It is operated by the U.S. National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI). Basgenbio analyzes TCGA data for the discovery of drug response markers and drug targets related to cancer, as well as external validation of internal results.

    *Year of Acquisition: 2022
    For research purposes
    K-BIOBANK UKB TCGA ADNI
    Total Number of Data * 3 Trillion 20 Trillion 9 Million 616 Trillion
    Total Capacity of Training Data ** 725 GB 2.6 TB 3 TB 1 TB
    Total Number of Subjects 156K+ 500K+ 10K+ 2K+
    Start Date of Subject Recruitment 2005 Year 2006 Year 2005 Year 2004 Year
    Types of Genomic Data Micro-array Micro-array /
    Whole Genome Sequencing
    / Whole Exome Sequencing     		Micro-array /
    RNA sequencing /
    Whole Genome Sequencing /
    Whole Exome Sequencing     		Micro-array /
    Whole Genome Sequencing
    Calculated as 'Total number of Participants' x 'Number of Variables,' and it is represented in Millions, Billions, or Trillions. HDD (Hard Disk Drive) capacity occupied by raw data

    Credit

    Project Manager
    Sol Lee